Table 4.
Phenotype | Control (PBS) | GM-MMB3.19 | non-GM-MMB3.19 |
---|---|---|---|
(Mean percentage expression ± SD) | |||
CD4eGFP+/CD8eGFP+ | 2.29 ± 1.56 | 2.15 ± 1.07 | 2.03 ± 0.79 |
CD4eGFP−/CD8eGFP− | 3.06 ± 1.37 | 3.82 ± 0.56 | 3.13 ± 0.91 |
CD4+CD44higheGFP+ | 2.85 ± 1.15 | 2.77 ± 1.21 | 2.74 ± 1.05 |
CD4+CD44higheGFP− | 1.68 ± 0.91 | 1.49 ± 0.70 | 1.50 ± 0.58 |
CD8+CD44higheGFP+ | 2.23 ± 2.03 | 2.38 ± 1.56 | 2.16 ± 1.56 |
CD8+CD44higheGFP− | 0.50 ± 0.35 | 0.46 ± 0.17 | 0.52 ± 0.20 |
Groups were compared using Kruskal-Wallis ANOVA test. No statistical differences were found for either phenotype